In a previous study where breast cancer cells were treated with DSB-inducing agents, Lin et al. [36] demonstrated that IGFBP-3 can form complexes with EGFR and DNA-PKcs after treatment with DNA-damaging drugs. Here, IGFBP3 is linked to breast cancer.